Role of ATGL and lipid metabolism in healthspan
ATGL 和脂质代谢在健康寿命中的作用
基本信息
- 批准号:9344823
- 负责人:
- 金额:$ 19.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-15 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adipose tissueAdrenergic AgentsAgingAging-Related ProcessAreaAutophagocytosisBiogenesisBiologicalBiologyBoxingCaloric RestrictionCatabolismCyclic AMPCyclic AMP-Dependent Protein KinasesDataDeacetylaseDietDietary FatsDiseaseDrosophila genusEnergy MetabolismEnvironmental Risk FactorEtiologyExerciseFOXO1A geneFRAP1 geneFastingFatty AcidsFatty acid glycerol estersGleanHealthHomologous GeneHumanIndividualInsulinKnock-in MouseKnowledgeLaboratoriesLinkLipaseLipidsLipolysisLiteratureLongevityLoxP-flanked alleleMammalsMediatingMetabolic DiseasesMetabolismMitochondriaModelingMusPPAR alphaPPAR gammaPharmacologic SubstancePhysiologicalPropertyProteinsRegulationRoleSignal PathwaySignal TransductionSomatotropinTestingTriglyceridesWorkage relatedagedbasefeedingflyimprovedinnovationinsightinsulin signalinglipid metabolismmouse modelmutantnovelnovel therapeuticsoverexpression
项目摘要
PROJECT SUMMARY
The biological underpinnings through which changes in diet or exercise influence healthspan - increased
lifespan in the absence of disease - are not fully understood. Recent data in flies and worms have highlighted
a potential role for lipolysis, the catabolism of triacylglycerol (TAG) stored within lipid droplets (LDs), as a factor
that promotes healthspan. However, the mechanisms linking lipolysis to alterations in healthspan are not
known. In addition, no studies have evaluated the role of lipolysis in healthspan regulation in mammals or the
interaction of lipolysis and diet, which largely determines the composition of LDs and, therefore, their signaling
properties. Thus, the objective of this application is to define the mechanisms through which lipolysis
influences healthspan and to determine the contribution of dietary lipid composition to these effects. We
hypothesize that lipolysis is a key signaling node that drives healthspan through alterations in fatty acid
signaling. We base this hypothesis on preliminary data from our laboratory defining a signaling axis linking
adipose triglyceride lipase (ATGL)-catalyzed lipolysis to sirtuin 1 (SIRT1) activity and downstream signaling to
activate forkhead box protein 01 (FOXO1). We also show that overexpression of the Drosophila homolog of
ATGL, brummer (Bmm), increases lifespan consistent the known roles of SIRT1 and FOXO1 as key regulators
of lifespan. To test our hypothesis, we will utilize the strengths of both Drosophila and mouse models to test
the following specific aims: Aim 1: To delineate the signaling pathway through which lipolysis influences
healthspan in Drosophila. We will use Drosophila models to dissect the linearity of the Bmm-Sir2 (fly SIRT1
homolog)-dFOXO (fly FOXO1 homolog) signaling axis in regulating healthspan. Aim 2: To determine the
interactions between diet and ATGL on healthspan in mice. These studies will explore the synergy
between dietary lipid composition and ATGL overexpression on lifespan and aging-related declines in
metabolism in mice. Aim 3: To characterize the interaction between ATGL and autophagy. In this aim,
will test the effects of ATGL on autophagy and the role of autophagy in mediating the signaling and lifespan
extending effects of ATGL/Bmm in both fly and mammalian models. These studies will be the first to
comprehensively define the role of ATGL-catalyzed lipolysis in healthspan and how it interacts other
physiological factors involved in lifespan regulation. These studies are innovative because they will use novel
fly and mouse models to link individual factors known to influence lifespan such as diet into a cohesive model
that better explains healthspan regulation. The proposed work is significant because it will greatly advance
our understanding into the understudied area of lipid metabolism as a factor contributing to aging and will
provide substantial insights into new or improved dietary, behavorial or pharmaceutical avenues to promote
healthspan.
项目概要
饮食或运动的改变影响健康寿命的生物学基础 - 增加
在没有疾病的情况下的寿命 - 尚未完全了解。苍蝇和蠕虫的最新数据突出显示
脂肪分解的潜在作用,即储存在脂滴 (LD) 内的三酰甘油 (TAG) 的分解代谢,作为一个因素
促进健康寿命。然而,脂肪分解与健康寿命改变之间的联系机制尚不明确。
已知。此外,还没有研究评估脂肪分解在哺乳动物或人类健康寿命调节中的作用。
脂肪分解和饮食的相互作用,很大程度上决定了 LD 的组成,从而决定了它们的信号传导
特性。因此,本申请的目的是确定脂肪分解的机制
影响健康寿命并确定膳食脂质成分对这些影响的贡献。我们
假设脂肪分解是通过脂肪酸的改变驱动健康寿命的关键信号节点
发信号。我们的这一假设基于我们实验室定义的信号轴链接的初步数据
脂肪甘油三酯脂肪酶 (ATGL) 催化脂肪分解产生沉默调节蛋白 1 (SIRT1) 活性和下游信号转导
激活叉头盒蛋白 01 (FOXO1)。我们还表明,果蝇同源物的过度表达
ATGL、brummer (Bmm) 可延长寿命,这与 SIRT1 和 FOXO1 作为关键调节因子的已知作用一致
的寿命。为了验证我们的假设,我们将利用果蝇和小鼠模型的优势来测试
具体目标如下: 目标 1:描绘脂肪分解影响的信号通路
果蝇的健康寿命。我们将使用果蝇模型来剖析 Bmm-Sir2(果蝇 SIRT1
同源物)-dFOXO(果蝇 FOXO1 同源物)信号轴在调节健康寿命中的作用。目标 2:确定
饮食和 ATGL 之间的相互作用对小鼠健康寿命的影响。这些研究将探讨协同作用
膳食脂质成分和 ATGL 过度表达对寿命和衰老相关下降的影响
小鼠的新陈代谢。目标 3:表征 ATGL 与自噬之间的相互作用。为了这个目标,
将测试 ATGL 对自噬的影响以及自噬在介导信号传导和寿命中的作用
ATGL/Bmm 在果蝇和哺乳动物模型中的扩展效应。这些研究将首先
全面定义 ATGL 催化脂肪分解在健康寿命中的作用以及它如何与其他物质相互作用
参与寿命调节的生理因素。这些研究具有创新性,因为他们将使用新颖的
苍蝇和小鼠模型将已知影响寿命的个体因素(例如饮食)连接到一个有凝聚力的模型中
这更好地解释了健康寿命的调节。拟议的工作意义重大,因为它将极大地推进
我们对脂质代谢作为导致衰老和意志的因素这一尚未研究的领域的理解
提供有关新的或改进的饮食、行为或药物途径的实质性见解,以促进
健康寿命。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Douglas G Mashek其他文献
Douglas G Mashek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Douglas G Mashek', 18)}}的其他基金
Lipid droplets and the compartmentalization of subcellular metabolism
脂滴和亚细胞代谢的区室化
- 批准号:
10589330 - 财政年份:2023
- 资助金额:
$ 19.83万 - 项目类别:
MUFA-SIRT1 signaling as a central node regulating healthspan
MUFA-SIRT1信号作为调节健康寿命的中心节点
- 批准号:
10092409 - 财政年份:2020
- 资助金额:
$ 19.83万 - 项目类别:
MUFA-SIRT1 signaling as a central node regulating healthspan
MUFA-SIRT1信号作为调节健康寿命的中心节点
- 批准号:
10646427 - 财政年份:2020
- 资助金额:
$ 19.83万 - 项目类别:
MUFA-SIRT1 signaling as a central node regulating healthspan
MUFA-SIRT1 信号传导作为调节健康寿命的中心节点
- 批准号:
10711019 - 财政年份:2020
- 资助金额:
$ 19.83万 - 项目类别:
MUFA-SIRT1 signaling as a central node regulating healthspan
MUFA-SIRT1信号作为调节健康寿命的中心节点
- 批准号:
10432079 - 财政年份:2020
- 资助金额:
$ 19.83万 - 项目类别:
MUFA-SIRT1 signaling as a central node regulating healthspan
MUFA-SIRT1信号作为调节健康寿命的中心节点
- 批准号:
10263268 - 财政年份:2020
- 资助金额:
$ 19.83万 - 项目类别:
Role of ATGL and lipid metabolism in healthspan
ATGL 和脂质代谢在健康寿命中的作用
- 批准号:
9285055 - 财政年份:2017
- 资助金额:
$ 19.83万 - 项目类别:
Regulation and consequences of hepatic lipid droplet catabolism
肝脏脂滴分解代谢的调节和后果
- 批准号:
9926393 - 财政年份:2017
- 资助金额:
$ 19.83万 - 项目类别:
Role of ATGL and lipid metabolism in healthspan
ATGL 和脂质代谢在健康寿命中的作用
- 批准号:
9902277 - 财政年份:2017
- 资助金额:
$ 19.83万 - 项目类别:
Regulation and consequences of hepatic lipid droplet catabolism
肝脏脂滴分解代谢的调节和后果
- 批准号:
9366252 - 财政年份:2017
- 资助金额:
$ 19.83万 - 项目类别:
相似国自然基金
记忆再巩固中去甲肾上腺素能系统在药物依赖戒断后潜伏心理渴求中的作用
- 批准号:82001404
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
肾上腺素能受体SNPs及PWV、CBP对射血分数保留心衰的发病及药物敏感性的影响
- 批准号:81471402
- 批准年份:2014
- 资助金额:70.0 万元
- 项目类别:面上项目
相似海外基金
A mechanism of lipid accumulation in brown adipose tissue
棕色脂肪组织中脂质积累的机制
- 批准号:
10605981 - 财政年份:2023
- 资助金额:
$ 19.83万 - 项目类别:
Transcriptional and epigenetic regulation of thermogenic adipocyte program
产热脂肪细胞程序的转录和表观遗传调控
- 批准号:
10604352 - 财政年份:2022
- 资助金额:
$ 19.83万 - 项目类别:
Deciphering age-dependent beige adipocyte failure
解读年龄依赖性米色脂肪细胞衰竭
- 批准号:
10589822 - 财政年份:2022
- 资助金额:
$ 19.83万 - 项目类别:
Defining the landscape and mechanisms of redox regulation of metabolism during aging
定义衰老过程中氧化还原代谢调节的景观和机制
- 批准号:
10616788 - 财政年份:2022
- 资助金额:
$ 19.83万 - 项目类别: